Boothbay Fund Management’s PolyPid PYPD Stock Holding History

Boothbay Fund Management’s Portfolio PYPD Stock Details PYPD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,063	Closed	-$44.5K	–	2003
2023 Q2	$44.5K	Sell	4,063 -34	-0.8%	-$409	﹤0.01%	1679
2023 Q1	$56.5K	Buy	4,097 +3,430	+514%	+$73K	﹤0.01%	2012
2022 Q4	$13.9K	Buy	667 +167	+33%	+$4.32K	﹤0.01%	1930
2022 Q3	$18K	Buy	+500	New	+$61.8K	﹤0.01%	2165

Other funds holding PYPD

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's PYPD Position: Q3 2023 in Review

Boothbay Fund Management sold out of PolyPid (PYPD) in Q3 2023, closing a stake of 4,063 shares — an estimated $44.5K sold.

Boothbay Fund Management first reported a position in PYPD in Q3 2022 and held it in 4 quarters. The position peaked at $56.5K in Q1 2023. 4 funds tracked by Wall St. Rank hold PYPD as of Q3 2023.

Boothbay Fund Management reported no remaining PolyPid position as of Q3 2023 after selling out during the quarter.
Boothbay Fund Management sold 4,063 PolyPid shares in Q3 2023, an estimated $44.5K.
Boothbay Fund Management first reported a position in PolyPid in Q3 2022 and held it in 4 quarters.
Boothbay Fund Management's PolyPid position peaked at $56.5K in Q1 2023.
4 funds tracked by Wall St. Rank held PolyPid as of Q3 2023.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.